Fig. 4From: Roles of METTL3 in cancer: mechanisms and therapeutic targetingPotential strategies for targeting of METTL3 in cancer. a A reported substrate competitive inhibitor of METTL3. b Protein-protein interaction (PPI)-based drug design. c Proteolysis-targeting chimera (PROTAC) for the degradation of METTL3 proteinBack to article page